Company Search:
Advanced Search
Sponsored Links
GlaxoSmithKline Pakistan Limited Company Snapshot
GlaxoSmithKline Pakistan Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline Pakistan Limited with three other companies in this sector in Pakistan: Sanofi Aventis Pakistan Ltd (2016 sales of 11.89 billion Pakistan Rupees [US$107.13 million] ), Ferozsons Laboratories Limited (11.34 billion Pakistan Rupees [US$102.13 million] ), and Abbott Laboratories (Pakistan) Ltd (23.39 billion Pakistan Rupees [US$210.73 million] of which 74% was Pharmaceutical).

Sales Analysis. During the year ended December of 2016, sales at GlaxoSmithKline Pakistan Limited were 27.56 billion Pakistan Rupees (US$248.35 million). This is an increase of 15.7% versus 2015, when the company's sales were 23.82 billion Pakistan Rupees. Despite this increase, sales are still slightly below the level achieved in 2014, when GlaxoSmithKline Pakistan Limited reported sales of 27.88 billion Pakistan Rupees.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
GlaxoSmithKline Pakistan Limited
  Stock Performance Chart for GlaxoSmithKline Pakistan Limited
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 183.60
(Figures in Pakistan Rupees)
1 Week -0.5%   13 Weeks 13.5%  
4 Weeks 10.3%   52 Weeks -27.1%  
GlaxoSmithKline Pakistan Limited Key Data:
  Ticker: GLAXO Country: Pakistan
  Exchanges: KAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 27,563,533,000
(Year Ending Jan 2017).
Employees: 2,323
  Currency: Pakistan Rupees Market Cap: 58,470,592,241
  Fiscal Yr Ends: December Shares Outstanding: 318,467,278
  Share Type: Ordinary Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.